CRISPR Studies Contradict Older Gene Research

CRISPR Studies Contradict Older Gene Research

It seemed like the perfect plan.

Jason Sheltzer, a cancer biologist at Cold Spring Harbor Laboratory in New York, was on the hunt for genes involved in tumour growth. He and his colleagues planned to disable genes using the popular gene-editing tool CRISPR–Cas9, then look for changes that reduced the rate at which cancer cells multiply. But they needed a control gene that would yield that same effect.

The literature suggested that the gene MELK was ideal: there was ample evidence that it is important in cancer-cell proliferation, and clinical trials are under way to test drugs that inhibit the MELK protein. But disabling the gene using CRISPR–Cas9 yielded no effect. “That threw a monkey wrench into our experiments,” says Sheltzer. “It brought everything to a halt.”

Read Full Article »
Show commentsHide Comments

Related Articles